Intercept Pharmaceuticals (ICPT) Stock Quadruples

Shares of Intercept Pharmaceuticals Inc. (ICPT) were trading up +88.13 or +31.58 percent to $363.00 per share in pre-market trading on Friday. The stock closed up +203.48 or +281.09 percent to $275.87 per share in Thursdayâ s regular trading session, after news that trials for the companyâ s new drug for non-alcoholic steatohepatitis (NASH) had been stopped after meeting the primary endpoint of the trial.

The so-called â

Published on Jan 10, 2014
By Jay Hawk
Jay Hawk
Jay Hawk enjoyed a 12-year professional financial markets career incorporating extensive first hand futures and options experience obtained by trading in the stock, commodity and forex markets on U.S. exchanges. Since retiring as a full-time financial market professional, he has been actively trading stock, commodities, forex and options for his own account and managing funds for others, as well as writing financial market commentary and educational articles.

Copyrighted 2020. Content published with author's permission.

Posted in ...